Zimmer Biomet Holdings, Inc. (ZBH) Q1 2019 Earnings Results

Zimmer Biomet Misses on EPS — Stock Down 0.69%

Zimmer Biomet's earnings report indicates a slight miss on EPS, which contributed to a modest decline in stock price. The company's cautious outlook reflects ongoing market challenges, and the lack of specific guidance may leave investors uncertain about future performance. The stock's reaction suggests that investors are weighing these factors carefully.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$1.87	N/A	-0.64%

Management

Management commentary

Tone: Cautiously Optimistic

Management acknowledged the current market conditions and expressed a commitment to improving operational performance. They remain focused on long-term growth despite short-term challenges.

Management highlighted ongoing challenges in the market.

They emphasized a focus on operational efficiency moving forward.

Zimmer Biomet Misses on EPS — Stock Down 0.69%

Key numbers

Management commentary

Zimmer Biomet Holdings, Inc.

More earnings this week

Zimmer Biomet Misses on EPS — Stock Down 0.69%

Key numbers

Management commentary